Skip to content

Strategies to Improve Asthma and Treatment of Asthma in Canadians

Strategies to Improve Diagnosis and Treatment of Asthma in Canadians

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01525381
Enrollment
701
Registered
2012-02-02
Start date
2011-11-30
Completion date
2016-03-31
Last updated
2016-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

Our study will enroll 644 randomly-selected Canadians who have been diagnosed with asthma by a physician within the previous five years. It will be determined what diagnostic tests were initially performed to make this diagnosis. Participants will undergo lung function testing over 6-8 weeks to determine their respiratory status and to confirm they have asthma. Participants may be followed up to one year depending on their test results.

Interventions

None listed

Sponsors

Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Patient must have a recent diagnosis of asthma by a physician. Diagnosis of asthma must have occurred within 5 years prior to entry into the study. 2. Patient must be at least 18 years old.

Exclusion criteria

1. Patients in whom methacholine challenge is contraindicated * Patients using chronic oral prednisone. * Patients with heart attack or stroke within three previous months, and those with known aortic or cerebral aneurysms. * Pregnant patients (unknown effect of methacholine on the fetus) and breastfeeding patients (unknown whether methacholine is excreted in breast milk). 2. Patients unable to provide informed consent. 3. Patients not able to perform spirometry and/or methacholine challenge testing. 4. Patients who have a greater than 10 pack-year smoking history (this will exclude patients with possible COPD). 5. Patients who currently have active pulmonary Tuberculosis 6. Patients who have had eye surgery in the past 3 months or who have a detached retina 7. Patients involved in another interventional asthma study

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026